Macclesfield, United Kingdom

Sebastien Louis Degeorge

This inventor holds 1 USPTO granted patent. Top assignee: Astrazeneca Ab. Active years: 2014.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Sebastien Louis Degeorge. Retrieved from https://idiyas.com/inventor/sebastien-louis-degeorge

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 10(Granted Patents)


Company Filing History:


Years Active: 2014

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Sebastien Louis Degeorge

Introduction

Sebastien Louis Degeorge is a notable inventor based in Macclesfield, GB. He has made significant contributions to the field of pharmaceuticals, particularly through his innovative work on chromenone derivatives.

Latest Patents

Degeorge holds a patent for chromenone derivatives, which are described by a specific formula. This invention includes pharmaceutically acceptable salts and outlines processes for their preparation. The patent also details pharmaceutical compositions containing these derivatives and their application in the treatment of cell proliferative disorders.

Career Highlights

Sebastien Louis Degeorge is associated with AstraZeneca AB, a leading global biopharmaceutical company. His work at AstraZeneca has allowed him to focus on developing new therapeutic solutions that address critical health challenges.

Collaborations

Throughout his career, Degeorge has collaborated with esteemed colleagues, including Bernard Barlaam and Christine Marie Paul Lambert-Van Der Brempt. These collaborations have further enhanced the impact of his research and innovations.

Conclusion

Sebastien Louis Degeorge's contributions to the field of pharmaceuticals through his patent on chromenone derivatives exemplify the importance of innovation in medical science. His work continues to influence the development of treatments for serious health conditions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…